PEBP1
PEBP1 (phosphatidylethanolamine binding protein 1) is a cytoplasmic member of the phosphatidylethanolamine-binding protein family that modulates several intracellular signalling pathways. It is also known as RKIP, HCNP, PEBP and PBP, and was previously named prostatic binding protein. Browse Assay Genie's current range of PEBP1 research reagents below, or read on for the biology behind the target.
PEBP1 belongs to the phosphatidylethanolamine-binding protein family and is found in the cytoplasm. It has been shown to modulate multiple signalling pathways, including the MAP kinase (MAPK), NF-kappa B and glycogen synthase kinase-3 (GSK-3) pathways. This breadth of activity makes PEBP1 a frequent subject in studies of how cells integrate and regulate kinase signalling.
The PEBP1 gene encodes a protein that can be processed further into a smaller cleavage product, hippocampal cholinergic neurostimulating peptide (HCNP). HCNP may be involved in neural development and in the function of presynaptic cholinergic neurons of the central nervous system. It increases the production of choline acetyltransferase but not acetylcholinesterase, and this effect appears to be mediated by a specific receptor. Orthologues of the human gene are present in mouse and rat, both named Pebp1.
The gene has been implicated in numerous human cancers and may act as a metastasis suppressor gene. The names RKIP, HCNP, PEBP and PBP are all used in the literature for this target, and the earlier name, prostatic binding protein, still appears in older references. Multiple pseudogenes of PEBP1 have been identified in the genome, which is worth considering when designing nucleic acid-based assays. Related family members, such as PEBP4, are studied alongside it.
PEBP1 has been implicated in numerous human cancers and may act as a metastasis suppressor gene.
PEBP1 modulates the MAP kinase pathway, making it relevant to work on kinase signalling control.
The protein also modulates NF-kappa B and GSK-3 signalling, so it is used to explore cross-talk between these pathways.
Its cleavage product HCNP may be involved in neural development and presynaptic cholinergic neuron function.
PEBP1 modulates several signalling pathways, including MAPK, NF-kappa B and GSK-3. It can also be processed into hippocampal cholinergic neurostimulating peptide (HCNP), which may be involved in neural development and increases choline acetyltransferase production.
PEBP1 is also called RKIP, HCNP, PEBP and PBP, and its earlier name was prostatic binding protein. HCNP also refers specifically to the smaller cleavage product, hippocampal cholinergic neurostimulating peptide, derived from the full-length protein.
PEBP1 has been implicated in numerous human cancers and may act as a metastasis suppressor gene. Mouse and rat each have an orthologue named Pebp1; check the datasheet of any product for its validated reactivity.
Other phosphatidylethanolamine-binding protein family members and related signalling targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P30086; product specifications from Assay Genie datasheets.